Despite its high prevalence and importance in the development of cancer, efforts to effectively target KRAS have long been futile as a consequence of micromolar GTP concentrations in cells (~0.5 mmol/L) combined with a picomolar affinity (dissociation constant at ~10-10 mol/L) of KRAS for GTP (9). Here, KRAS is linked to cancer.